Acute ischaemic stroke
Pro Research Analysisby 
Searched over 200M research papers
Acute Ischaemic Stroke: Rapid Assessment and Early Intervention
Acute ischaemic stroke is a medical emergency where quick assessment and early intervention are critical for improving patient outcomes. Time is crucial, as rapid evaluation and treatment can help save brain tissue and reduce long-term disability. Advanced imaging techniques are now used to assess brain perfusion and identify patients who may benefit most from available therapies, allowing for more targeted and effective treatment strategies 1210.
Reperfusion Therapies: Thrombolysis and Mechanical Thrombectomy
The main goal in treating acute ischaemic stroke is to restore blood flow to the affected brain area as quickly as possible. The cornerstone treatments are intravenous thrombolysis, typically with recombinant tissue plasminogen activator (rt-PA), and endovascular mechanical thrombectomy. Thrombolysis is most effective when given within a few hours of symptom onset, but only a small percentage of patients meet the strict criteria for this therapy. Mechanical thrombectomy, especially for large vessel occlusions, has shown substantial benefits and can be performed up to 24 hours after symptom onset in selected patients 2356+3 MORE.
Importance of Stroke Centers and Systems of Care
The development of specialized stroke centers and organized systems of care has revolutionized the management of acute ischaemic stroke. These systems ensure rapid recognition of symptoms, efficient triage, and immediate access to advanced treatments. Early admission to dedicated stroke units allows for close monitoring, prevention of complications, and timely secondary prevention strategies 12810.
Monitoring and Prevention of Secondary Complications
After initial reperfusion therapy, meticulous management of systemic factors such as blood pressure, blood glucose, oxygenation, and body temperature is essential. Preventing secondary insults like hypotension, hyperthermia, and hyperglycaemia can minimize further brain injury and improve outcomes. Neurological deterioration can occur due to infarct extension, hemorrhagic transformation, or cerebral edema, so continuous monitoring is vital 356.
Advances in Imaging and Patient Selection
Modern neuroimaging plays a central role in diagnosing stroke, differentiating between stroke subtypes, and selecting patients for advanced therapies. Imaging helps identify the ischaemic penumbra—brain tissue at risk but still salvageable—guiding decisions about thrombolysis and thrombectomy, even in extended time windows 1247+1 MORE.
Experimental and Adjunctive Therapies
Research continues into new treatments for acute ischaemic stroke. Experimental approaches include combining antiplatelet agents with thrombolysis, using new thrombolytic drugs, and testing novel endovascular devices. Neuroprotective strategies, such as therapeutic hypothermia, are also being studied for their potential to protect brain tissue when used alongside reperfusion therapies, though conclusive evidence is still pending 47910.
Barriers and Future Directions
Despite advances, many patients who could benefit from mechanical thrombectomy do not have access to this procedure. Expanding access, improving emergency networks, and learning from other interventional programs are key goals. Ongoing research aims to extend therapeutic windows, refine patient selection, and develop new neuroprotective agents to further improve outcomes 27810.
Conclusion
Acute ischaemic stroke management has advanced significantly with the introduction of rapid assessment, specialized stroke centers, and effective reperfusion therapies. Continued improvements in imaging, patient selection, and access to care, along with ongoing research into new treatments, are essential for reducing disability and death from this condition 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic